<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.7150/thno.59418</dc:identifier><dc:language>eng</dc:language><dc:creator>Uranga-Murillo I.</dc:creator><dc:creator>Tapia E.</dc:creator><dc:creator>Garzón-Tituaña M.</dc:creator><dc:creator>Ramirez-Labrada A.</dc:creator><dc:creator>Santiago L.</dc:creator><dc:creator>Pesini C.</dc:creator><dc:creator>Esteban P.</dc:creator><dc:creator>Roig F.J.</dc:creator><dc:creator>Galvez E.M.</dc:creator><dc:creator>Bird P.I.</dc:creator><dc:creator>Pardo Jimeno,  J.</dc:creator><dc:creator>Arias M.</dc:creator><dc:title>Biological relevance of Granzymes A and K during E. coli sepsis</dc:title><dc:identifier>ART-2021-127144</dc:identifier><dc:description>Aims: Recent in vitro findings suggest that the serine protease Granzyme K (GzmK) may act as a proinflammatory mediator. However, its role in sepsis is unknown. Here we aim to understand the role of GzmK in a mouse model of bacterial sepsis and compare it to the biological relevance of Granzyme A (GzmA). Methods: Sepsis was induced in WT, GzmA-/- and GzmK-/- mice by an intraperitoneal injection of 2x108 CFU from E. coli. Mouse survival was monitored during 5 days. Levels of IL-1a, IL-1ß, TNFa and IL-6 in plasma were measured and bacterial load in blood, liver and spleen was analyzed. Finally, profile of cellular expression of GzmA and GzmK was analyzed by FACS. Results: GzmA and GzmK are not involved in the control of bacterial infection. However, GzmA and GzmK deficient mice showed a lower sepsis score in comparison with WT mice, although only GzmA deficient mice exhibited increased survival. GzmA deficient mice also showed reduced expression of some proinflammatory cytokines like IL1-a, IL-ß and IL-6. A similar result was found when extracellular GzmA was therapeutically inhibited in WT mice using serpinb6b, which improved survival and reduced IL-6 expression. Mechanistically, active extracellular GzmA induces the production of IL-6 in macrophages by a mechanism dependent on TLR4 and MyD88. Conclusions: These results suggest that although both proteases contribute to the clinical signs of E. coli-induced sepsis, inhibition of GzmA is sufficient to reduce inflammation and improve survival irrespectively of the presence of other inflammatory granzymes, like GzmK.</dc:description><dc:date>2021</dc:date><dc:source>http://zaguan.unizar.es/record/151349</dc:source><dc:doi>10.7150/thno.59418</dc:doi><dc:identifier>http://zaguan.unizar.es/record/151349</dc:identifier><dc:identifier>oai:zaguan.unizar.es:151349</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA/B29-17R</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MCIU-AEI/PID2020-113963RB-I00	 Desasignar</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MCIU-AEI/SAF2017-83120-C2-1-R</dc:relation><dc:identifier.citation>Theranostics 11, 20 (2021), 9873-9883</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>https://creativecommons.org/licenses/by/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>